Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T51426 | Target Info | |||
Target Name | Farnesoid X-activated receptor (FXR) | ||||
Synonyms | Retinoid X receptor-interacting protein 14; RXR-interacting protein 14; RIP14; Nuclear receptor subfamily 1 group H member 4; HRR1; Farnesol receptor HRR-1; FXR; Bile acid receptor; BAR | ||||
Target Type | Successful Target | ||||
Gene Name | NR1H4 | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 2-[2-[[3-[2,6-Bis(chloranyl)phenyl]-5-cyclopropyl-1,2-oxazol-4-yl]methoxy]-6-azaspiro[3.4]octan-6-yl]-1,3-benzothiazole-6-carboxylic acid | Ligand Info | |||
Canonical SMILES | C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4CC5(C4)CCN(C5)C6=NC7=C(S6)C=C(C=C7)C(=O)O | ||||
InChI | 1S/C28H25Cl2N3O4S/c29-19-2-1-3-20(30)23(19)24-18(25(37-32-24)15-4-5-15)13-36-17-11-28(12-17)8-9-33(14-28)27-31-21-7-6-16(26(34)35)10-22(21)38-27/h1-3,6-7,10,15,17H,4-5,8-9,11-14H2,(H,34,35) | ||||
InChIKey | NNWXFKHVPXSNGU-UHFFFAOYSA-N | ||||
PubChem Compound ID | 130224663 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6A5Y Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC143 and 9cRA and SRC1 | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | Yes | [1] |
PDB Sequence |
ELTPDQQTLL
253 HFIMDSYNKQ263 RMPQEITNKI273 LKEEFSAEEN283 FLILTEMATN293 HVQVLVEFTK 303 KLPGFQTLDH313 EDQIALLKGS323 AVEAMFLRSA333 EIFNKKLPSG343 HSDLLEERIR 353 NSGISDEYIT363 PMFSFYKSIG373 ELKMTQEEYA383 LLTAIVILSP393 DRQYIKDREA 403 VEKLQEPLLD413 VLQKLCKIHQ423 PENPQHFAEL433 LGRLTELRTF443 NHHHAEMLMS 453 WRVNDHKFTP463 LLEEIWDV
|
|||||
|
MET265
3.439
THR270
3.697
ILE273
3.456
PHE284
3.811
LEU287
3.578
THR288
3.626
MET290
3.822
ALA291
3.413
HIS294
3.996
VAL325
4.679
MET328
3.601
PHE329
3.523
ARG331
3.972
SER332
3.208
ILE335
3.516
|
|||||
PDB ID: 6A5W FXR-LBD with HNC143 and SRC1 | ||||||
Method | X-ray diffraction | Resolution | 2.88 Å | Mutation | Yes | [1] |
PDB Sequence |
ELTPDQQTLL
253 HFIMDSYNKQ263 RMPQEITNKI273 LKEEFSAEEN283 FLILTEMATN293 HVQVLVEFTK 303 KLPGFQTLDH313 EDQIALLKGS323 AVEAMFLRSA333 EIFNKKLPSG343 HSDLLEERIR 353 NSGISDEYIT363 PMFSFYKSIG373 ELKMTQEEYA383 LLTAIVILSP393 DRQYIKDREA 403 VEKLQEPLLD413 VLQKLCKIHQ423 PENPQHFAEL433 LGRLTELRTF443 NHHHAEMLMS 453 WRVNDHKFTP463 LLEEIWDV
|
|||||
|
MET265
3.759
THR270
3.631
ILE273
3.601
PHE284
3.919
LEU287
3.481
THR288
3.497
MET290
3.350
ALA291
3.642
HIS294
3.925
MET328
3.349
PHE329
3.350
ARG331
3.923
SER332
3.381
ILE335
3.387
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Ligand binding and heterodimerization with retinoid X receptor Alpha (RXRAlpha) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding. J Biol Chem. 2018 Nov 23;293(47):18180-18191. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.